Context Some of the high costs of robot-assisted radical prostatectomy (RARP), intensity-
modulated radiotherapy (IMRT), and proton beam therapy may be offset by better outcomes …

Prostate cancer is a significant public health burden and a major cause of morbidity and
mortality among men worldwide. Analyzing geographic patterns and temporal trends may …

Context There is little level 1 evidence regarding the relative efficacy of radical
prostatectomy (RP) compared with radiotherapy (RT) combined with androgen deprivation …

Background: Prostate cancer is the second most common cancer in males worldwide, and
its incidence is rising. Early detection is crucial for improving the outcomes, but the current …

Purpose There is a major clinical need to devise an optimal treatment sequence for the
multiple therapy options available for patients with metastatic castration-resistant prostate …

Objective To assess the health‐related quality of life (HRQ oL) of patients with prostate
cancer up to 24 months after treatment in a contemporary large diverse population. Patients …

Despite excellent oncologic outcomes, the management of localized prostate cancer
remains complex and is dependent on multiple factors, including patient life expectancy …

Prostate cancer is a common malignancy, but only some tumors are lethal. Accurately
identifying these tumors will improve clinical practice and instruct research. Aggressive …

Objectives To describe real‐world clinical and functional outcomes in an Australian cohort of
men with localised prostate cancer according to treatment type and risk category. Subjects …

Simple Summary Real-world data (RWD), ie, data reflecting normal clinical practice
collected outside the constraints of randomised controlled trials, provide important insights …